Abstract: Primary hyperaldosteronism (Conn's syndrome) was described for the first time by the Polish internist Michał
Primary hyperaldosteronism is a traditional term of rare form of renin-angiotensin-independent mineralocorticoid excess syndrome resulting from an autonomous secretion of the hormone by an adenoma, carcinoma or hyperplasia of the glomerular zone of the adrenal glands. Metabolic defects, usually inherited, are other cause of aldosterone excess in patients with primary hyperaldosteronism. Primary hyperaldosteronism is known in medical literature as Conn's syndrome. The symptoms of this clinical condition are skeletal muscle weakness or intermittent paralysis, polyuria, hypertension and cardiac arrhythmias. The symptoms are associated with hyperkalemia, sodium retention and alkalosis.
The first description of primary hyperaldosteronism is commonly attributed to Jerome W. Conn who in 1955 reported a 34-year-old female patient with weakness and periodical paralysis of the lower extremities and frequently recurrent numbness with cramping of her hands lasting for 7 years prior to hospital admission. Jerome W. Conn presented the case at his presidential address to the Central Society for Clinical Research on October 29, 1955 [1] . In the same year, the report was published in the Journal of Laboratory and Clinical Medicine [2] . Later, Jerome W. Conn published other papers and reviews on primary hyperaldosteronism [3] .
Conn's description is considered the first report on primary hyperaldosteronism in medical literature although more than two years earlier, two cases of malignant hypertension caused by tumors of adrenal gland cortex had been published by a Polish internist Michał Lityński [4] . He reported two male patients who died due to malignant hypertension and renal insufficiency caused by hypertension, and in whom autopsy revealed a tumor in the adrenal glands. The first 48-year-old man had a tumor in both adrenal glands (tumor diameter 24 mm, 30 mm respectively) while in the second one, 44-yearold individual a large tumor of the right adrenal gland was discovered at autopsy (the gland measured 6 x 5 x 1.5 cm). Microscopic evaluation of the tumors revealed that they consisted of large cells surrounded by blood vessels. The cells had foamy cytoplasm and small nuclei, and resembled those of the glomerular zone of the adrenal gland. Clinically both patients had symptoms of severe malignant hypertension and in the last stage of the disease symptoms of renal insufficiency. Blood pressure in both was 240/150 mmHg. In conclusion Michał Lityński wrote: "One can suppose that in both cases hypertension was caused by adrenocortical tumors, bilateral in one case, and localized in the right adrenal gland in the other case. In the structure of the tumors, proliferation of the cells resembling those of the glomerular zone was found; which secretes mineralocorticoids. This finding suggests that in both cases overproduction of the hormones had took place". The paper of The description by Michał Lityński was forgotten and almost unknown even in Polish medical literature. In 1983, the Lityński's paper was mentioned in the book of Walentyna Hartwig [8] and in 1984 by Franciszek Kokot [9] . A few years later, Tadeusz Marcinkowski proposed to rename the syndrome as "Lityński-Conn syndrome" [10] . In 1991, "Lancet" published a letter indicating the priority of Michał Lityński in discovery of primary hyperaldosteronism [11] , and subsequently Norman Kaplan has included a note on the first description of the disease by Michał Lityński in a new edition of his "Hypertension". Lityński's name also appeared in reviews on the history of endocrinology. 
